April 2015

The Retina Specialist's Role in Systemic Diabetes Control

Robert L. Avery, MD, Associate Medical Editor and Allen C. Ho, MD, Chief Medical Editor

News

Additional Perspectives on Protocol T

Some aspects of the trial may warrant closer scrutiny before clinicians begin to change practice patterns.

Bryan Bechtel, Editor-in-Chief

Medical Update

SGR: What Is It, Why Is It Important, and What Does It Mean for Ophthalmology?

An Interview with Michael X. Repka, MD

Gene Therapy for Retinal Diseases

Aron Shapiro

Advice For Incoming Second-Year Fellows

S. K. Steven Houston III, MD

Solutions For a Pair of Puzzling Surgical Coding Issues

A review of two common questions regarding coding for unique situations.

Riva Lee Asbell

Pearls for Pediatric Retina Surgery

Audina Berrocal, MD, and Michael Trese, MD

Internal Limiting Membrane: Making the Decision to Peel

The decision should be based on the patient's disease condition.

Chi-Chun Lai, MD

Noninfectious Uveitis: New Treatment Possibilities with Intravitreal Immunoregulatory Therapy

Quan Dong Nguyen, MD, MSc

Stunning Visualization of Fetal Hyaloid Artery

Sugandha Singh, BA; Murat Hasanreisoglu, MD; Renelle Pointdujour Lim, MD; and Carol L. Shields, MD

Laser Pointer Retinal Injures

Injury from laser pointer trauma is a public health problem on the rise.

Gregory D. Lee, MD, and David R. Lally, MD

Different Fellowship Structures

The differing structures of fellowship programs create a field of doctors with diverse experience.

Jessica Randolph, MD; Joshua Mali, MD; and Ashleigh Levison, MD

The Value of Mentorship Inside and Outside the OR

Mentorship, which keeps retina alive, occurs in places other than the OR.

Denis Jusufbegovic, MD, and Ahmet Ozkok, MD

What Is New with Anti-VEGF Therapy for DME

A wealth of evidence supports anti-VEGF therapy in DME.

Dilsher S. Dhoot, MD, and Dante Pieramici, MD

The DME Pipeline

The outlook for new therapies for diabetic macular edema is bright—and it will have to be to meet the rising demand for treatment.

Peter K. Kaiser, MD

The Role of Corticosteroid Implants in DME

Sustained-release platforms offer an alternative solution for patients with inadequate or no response to anti-VEGF therapy while addressing important compliance issues.

Nancy Holekamp, MD

What is the Current Role of Laser Therapy in the Management of DME?

Subthreshold laser may provide a viable adjunct to pharmacologic therapy in selected patients.

Sam E. Mansour, MSc, MD, FRCS(C), FACS

Crowdsourcing for Rapid Fundus Photograph Interpretation

Third-party interpretations of fundus photographs could lighten the burden on retina specialists.

Christopher J. Brady, MD

Switching Therapy in Patients with DME

Three physicians offer their thoughts on when and why they consider changing therapy modalities.

David Eichenbaum, MD; John W. Kitchens, MD; and Andrew A. Moshfeghi, MD, MBA

Ultra-Widefield Imaging: Advancing the Understanding and Management of Diabetic Retinopathy

Routine, rapid visualization of the retinal periphery will facilitate earlier diagnosis, more accurate evaluation, and better treatment outcomes.

Paul E. Tornambe, MD, FACS

5Q with Shlomit Schaal, MD, PhD

Shlomit Schaal, MD, PhD, is an Associate Professor, Director of the Retina Service, and Director of the Vitreoretinal Fellowship Program at the University of Louisville School of Medicine, Kentucky.